The kit is designed to control the correctness of in vitro determination of f. VIII activity in plasma of donors, in plasma of haemophilia A patients, in plasma of patients with thrombophilia with high f.VIII levels and in therapeutic preparations of cryoprecipitate and fresh frozen plasma (FFP).
Plasma control pathological with reduced (about 20%) and with increased level of factor VIII (about 200%) is used for quality control of coagulation factor VIII activity determination by unified one-stage clotting method: in plasma of donors in plasma of patients with haemophilia A; in plasma of patients with thrombophilic conditions caused by high level of factor VIII activity; in therapeutic preparations of cryoprecipitate (factor VIII). Set composition: plasma with 20% activity of factor VIII, lyophilically dried (1.0 ml) - 3 vials; plasma with 200% activity of factor VIII, lyophilically dried (1.0 ml) - 3 vials.
أخبرنا بما تحتاجه واحصل على عروض أسعار من موردين موثوقين